Welcome to a new type of webinar. We invite you to leave your everyday tactical concerns aside for a moment – trust me, you won’t forget them – and take a moment to consider the future of our industry.
As pharma’s customer landscape becomes more complex, our perception of value has changed. Just you wouldn’t be caught dead wearing those flares that were once your most prized possession, it’s no longer enough to focus only on the medicine.
What worked ten years ago does simply not feel right anymore and, increasingly, our customers require more comprehensive solutions.
So what are the disease-specific, technically-specific or customer-specific competencies that will create a new set of assets? How will the medicines we develop require new ways of operating and interacting with our customer?
These questions might feel futuristic, but it is already happening. The recent approval of Novartis’ Kymriah was dependent on a more sophisticated supply chain, and the ability to develop a robust outcomes-based payment model, two things that Novartis had the capacity to execute – but historically, not competencies any of us have considered necessary to have in-house.
Register now for this exceptional webinar!
Director, Healthcare Systems, Novartis
Vice President of Pharmaceutical Innovation, AstraZeneca
Director Life Sciences, PA Consulting Group
Director, Pharmaforensic Ltd